Exploring the Role of T-VEC in the Treatment of Metastatic Melanoma

February 28, 2018
Robert Andtbacka, MD

Robert Andtbacka, MD, associate professor in the Division of Surgical Oncology, Department of Surgery at the University of Utah School of Medicine, discusses a study exploring the role of talimogene laherparapvec (T-VEC; Imlygic) in the treatment of patients with metastatic melanoma.